Overview
Background
Dr Mollee practices as a consultant haematologist in clinical and laboratory haematology at the Princess Alexandra Hospital and is Associate Professor with the University of Queensland Medical School.
Having trained in Brisbane and Toronto, Dr Mollee has developed an international reputation studying amyloidosis and the plasma cell dyscrasias. He holds appointments with the Medical Scientific Advisory Group of Myeloma Australia, Australian Amyloidosis Network, National Blood Cancer Taskforce and is a member of the AACB Monoclonal Gammopathy Working Group and the International Kidney & Monoclonal Gammopathy Research Group. He is a past Chairman of the Australasian Leukaemia and Lymphoma Group (ALLG) and current Chair of the Australian Amyloidosis Network. He heads the Myeloma Service as well as the Queensland Amyloidosis Centre which runs one of the few clinics in Australia dedicated exclusively to the care of patients with amyloidosis.
Availability
- Associate Professor Peter Mollee is:
- Available for supervision
Qualifications
- Masters (Coursework) of Medical Science, University of Newcastle
- Royal Australasian College of Physicians, Royal Australasian College of Physicians
- Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia
Research impacts
The research of the Queensland Amyloidosis Centre aims to improved the diagnosis, monitoring and therapy of all types of amyloidosis. The Centre, in collaboration with Pathology Queensland and the Translational Research Institute, developed laser capture macrodisscution and tandem mass spectrometry analysis to accurately diagnosis the type of amyloidosis that patients have and have introuduced this assay into the clinical laboratory. Research to improve the diagnosis and monitoring of this rare disease has also assessed immunoglobulin free light chain assays, bone scintigraphy and novel radionuclide PET tracers. The Queensland Amyloidosis Centre maintains an active clinical trial program in amyloidosis therapies including both investigator-initiated and commercial studies.
Works
Search Professor Peter Mollee’s works on UQ eSpace
2005
Journal Article
Increased Lipid Concentration Is Associated with Increased Hemolysis
Dimeski, Goce, Mollee, Peter and Carter, Andrew (2005). Increased Lipid Concentration Is Associated with Increased Hemolysis. Clinical Chemistry, 51 (12), 2425-2425. doi: 10.1373/clinchem.2005.058644
2005
Conference Publication
Falsely low serum free light chain concentration in patients with monoclonal light chain diseases
Mollee, Peter, Tate, Jill, Dimeski, Goce and Gill, Devinder (2005). Falsely low serum free light chain concentration in patients with monoclonal light chain diseases. 47th ASH Annual Meeting, Atlanta, GA United States, 10-13 December 2005. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v106.11.5077.5077
2005
Conference Publication
Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL)
Lane, Steven W., Mollee, Peter N., Bird, Robert, Porceddu, Sandro and Gill, Devinder (2005). Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL). 47th ASH Annual Meeting, Atlanta, GA United States, 10-13 December 2005. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v106.11.4993.4993
2005
Journal Article
Role of VAD in the initial treatment of multiple myeloma
Lane, Steven W., Gill, Devinder, Mollee, Peter N. and Rajkumar, S. Vincent (2005). Role of VAD in the initial treatment of multiple myeloma. Blood, 106 (10), 3674-3675. doi: 10.1182/blood-2005-07-2610
2005
Journal Article
The reporting of serum protein electrophoresis to clinicians
Tate, Jillian R., Mollee, Peter and Gill, Devinder (2005). The reporting of serum protein electrophoresis to clinicians. Clinica Chimica Acta, 358 (1-2), 204-205. doi: 10.1016/j.cccn.2005.04.010
2005
Journal Article
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission
Song, Kevin W., Mollee, Peter N., Hogge, Donna E., Gupta, Vikas, Bernett, Michael J., Forrest, Donna L., Lavoie, Julye C., Nevill, Thmas J., Nantel, Stephen H., Shepherd, John D., Smith, Clay A., Sutherland, Heather J., Toze, Cynthia L., Crump, Michael and Keating, Armand (2005). Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission. Leukemia and Lymphoma, 46 (4), 525-531. doi: 10.1080/10428190400025112
2005
Journal Article
Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?
Rifkind, Joshua, Mollee, Peter, Messner, Hans and Lipton, Jeffrey (2005). Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?. Leukemia & Lymphoma, 46 (2), 217-223. doi: 10.1080/10428190400015022
2005
Journal Article
Serum free light chains for monitoring multiple myeloma
Tate, J., Mollee, P. and Gill, D. (2005). Serum free light chains for monitoring multiple myeloma. British Journal of Haematology, 128 (3), 405-406. doi: 10.1111/j.1365-2141.2004.05338.x
2005
Conference Publication
A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma
Kuruvilla, J., Mollee, P., Song, K., Zaretsky, Y., Panzarella, T., McCrae, J., Nagy, T., Crump, M. and Keating, A. (2005). A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma. 9th International Conference on Malignant Lymphoma, Lugano, Switzerland, 9 -11 June 2005. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdi582
2005
Conference Publication
Pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) with hyper-CVAD chemotherapy regimen for aggressive lymphoid malignancy.
Lane, SW, Crawford, J, Kenealy, M, Cull, G, Seymour, JF, Prince, M, Marlton, P, Gill, D and Mollee, PN (2005). Pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) with hyper-CVAD chemotherapy regimen for aggressive lymphoid malignancy.. 47th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA, United States, 10-13 December 2005. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood.V106.11.4274.4274
2005
Conference Publication
Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL)
Lane, S. W., Mollee, P. N., Bird, R., Porceddu, S. and Gill, D. (2005). Aggressive cutaneous squamous cell carcinoma (SCC) in chronic lymphocytic leukaemia (CLL). 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, United States, 10-13 December 2005. Washington, DC, United States: American Society of Hematology.
2005
Conference Publication
Falsely low serum free light chain concentration in patients with monoclonal light chain diseases
Mollee, Peter, Tate, Jill, Dimeski, Goce and Gill, Devinder (2005). Falsely low serum free light chain concentration in patients with monoclonal light chain diseases. 47th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA, United States, 10-13 December 2005. Washington, DC, United States: American Society of Hematology.
2005
Conference Publication
Accelerated delivery of Rituximab is safe on an out-patient basis.
Middleton, HJ, Mollee, P, Bird, R, Mills, AK, Marlton, P and Gill, D (2005). Accelerated delivery of Rituximab is safe on an out-patient basis.. 47th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, Dec 10-13, 2005. WASHINGTON: AMER SOC HEMATOLOGY.
2005
Journal Article
Stem cell transplantation for mantle cell lymphoma: if, when and how?
Kiss, T. L., Mollee, P., Lazarus, H. M. and Lipton, J. H. (2005). Stem cell transplantation for mantle cell lymphoma: if, when and how?. Bone Marrow Transplantation, 36 (8), 655-661. doi: 10.1038/sj.bmt.1705080
2005
Conference Publication
Falsely low serum free light chain concentration in patients with monoclonal light chain diseases
Tate, J.R., Mollee, P., Dimeski, G. and Gill, D. (2005). Falsely low serum free light chain concentration in patients with monoclonal light chain diseases. Annual Meeting of the American Association Clinical Chemistry, Orlando, FL, United States, 24-28 July 2005. Washington, DC, United States: American Association for Clinical Chemistry.
2004
Conference Publication
Optimal timing of peripheral blood stem cell mobilisation in patients with hematological malignancies treated with the hyper-CVAD chemotherapy regimen
Mills, AK, Gibbs, S, Keane, C, Mollee, P, Grimmett, K, Van Kuilenburg, R, Saal, R, Gill, D, Prince, HM, Seymour, JF and Marlton, P (2004). Optimal timing of peripheral blood stem cell mobilisation in patients with hematological malignancies treated with the hyper-CVAD chemotherapy regimen. 46th Annual Meeting of the American-Society-of-Hematology, San Diego Ca, Dec 04-07, 2004. WASHINGTON: AMER SOC HEMATOLOGY.
2004
Conference Publication
Serum free light chain ratios do not detect relapse in some patients with intact immunoglobulin myeloma post autologous peripheral blood stem cell transplantation.
Tate, JR, Mollee, P and Gill, D (2004). Serum free light chain ratios do not detect relapse in some patients with intact immunoglobulin myeloma post autologous peripheral blood stem cell transplantation.. 56th Annual Meeting of the American-Association-for-Clinical-Chemistry, Los Angeles Ca, Jul 25-29, 2004. WASHINGTON: AMER ASSOC CLINICAL CHEMISTRY.
2004
Journal Article
Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia
Mollee, P., Gupta, V., Song, K., Reddy, V., Califaretti, N., Tsang, R., Crump, M. and Keating, A. (2004). Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia. Bone Marrow Transplantation, 33 (12), 1201-1208. doi: 10.1038/sj.bmt.1704506
2004
Journal Article
Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome
Mollee, P. N., Wechalekar, A. D., Pereira, D. L., Franke, N., Reece, D., Chen, C. and Stewart, A. K. (2004). Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Bone Marrow Transplantation, 33 (3), 271-277. doi: 10.1038/sj.bmt.1704344
2004
Journal Article
Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia
Mollee, P., Arthur, C., Hughes, T., Januszewicz, H., Grigg, A., Bradstock, K., Wolf, M., Gibson, J., Schwarer, A. P., Spencer, A., Browett, P., Hawkins, T., Seldon, M., Herrmann, R. and Watson, A. (2004). Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia. Annals of Oncology, 15 (12), 1810-1815. doi: 10.1093/annonc/mdh468
Supervision
Availability
- Associate Professor Peter Mollee is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Master Philosophy
Novel Radionuclide Tracers for Imaging in Amyloidosis
Principal Advisor
Other advisors: Associate Professor Colm Keane
-
Doctor Philosophy
Addressing frailty in older people with haematological malignancies
Associate Advisor
Other advisors: Associate Professor Emily Gordon, Dr Natasha Reid, Professor Ruth Hubbard
Media
Enquiries
For media enquiries about Associate Professor Peter Mollee's areas of expertise, story ideas and help finding experts, contact our Media team: